Related Experiment Video
Updated: Oct 12, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Immediate oral versus immediate topical versus delayed oral antibiotics for children with acute otitis media with
Alastair D Hay1, Michael V Moore2, Jodi Taylor3
1Centre for Academic Primary Care, Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Insights
This study on acute otitis media in children could not determine the best antibiotic strategy due to low recruitment. Electronic platform issues hindered progress, highlighting challenges for future primary care trials.
Area of Science:
- Pediatrics
- Infectious Diseases
- Clinical Trials
Background:
- Acute otitis media (AOM) with discharge is common in children and can cause significant discomfort.
- Spontaneous eardrum perforation leading to otorrhoea is a frequent complication.
Purpose of the Study:
- To compare the clinical effectiveness and economic impact of immediate topical antibiotics, delayed oral antibiotics, and immediate oral antibiotics for AOM with discharge.
- To reduce symptom duration in pediatric patients presenting to primary care.
Main Methods:
- A pragmatic, three-arm, individually randomised, open-label trial.
- Utilized a health-record-integrated electronic trial platform (TRANSFoRm) for recruitment and data collection.
- Included economic and qualitative evaluations.
Main Results:
- The trial closed early due to insufficient recruitment (22 children randomized vs. planned 399).
- Median symptom resolution was 6 days for immediate oral, 4 days for delayed oral, and 4 days for immediate topical antibiotics.
- Software issues significantly impacted recruitment and burdened staff.
Conclusions:
- The study could not answer the primary research question due to failure to reach the required sample size.
- Experience highlighted significant challenges with electronic platforms in primary care research.
- Recommendations are provided for future NIHR-supported trials using similar platforms.
Background:
Acute otitis media is a painful infection of the middle ear that is commonly seen in children. In some children, the eardrum spontaneously bursts, discharging visible pus (otorrhoea) into the outer ear.
Objective:
To compare the clinical effectiveness of immediate topical antibiotics or delayed oral antibiotics with the clinical effectiveness of immediate oral antibiotics in reducing symptom duration in children presenting to primary care with acute otitis media with discharge and the economic impact of the alternative strategies.
Design:
This was a pragmatic, three-arm, individually randomised (stratified by age < 2 vs. ≥ 2 years), non-inferiority, open-label trial, with economic and qualitative evaluations, supported by a health-record-integrated electronic trial platform [TRANSFoRm (Translational Research and Patient Safety in Europe)] with an internal pilot.
Setting:
A total of 44 English general practices.
Participants:
Children aged ≥ 12 months and < 16 years whose parents (or carers) were seeking medical care for unilateral otorrhoea (ear discharge) following recent-onset (≤ 7 days) acute otitis media.
Interventions:
(1) Immediate ciprofloxacin (0.3%) solution, four drops given three times daily for 7 days, or (2) delayed 'dose-by-age' amoxicillin suspension given three times daily (clarithromycin twice daily if the child was penicillin allergic) for 7 days, with structured delaying advice. All parents were given standardised information regarding symptom management (paracetamol/ibuprofen/fluids) and advice to complete the course.
Comparator:
Immediate 'dose-by-age' oral amoxicillin given three times daily (or clarithromycin given twice daily) for 7 days. Parents received standardised symptom management advice along with advice to complete the course.
Main Outcome Measure:
Time from randomisation to the first day on which all symptoms (pain, fever, being unwell, sleep disturbance, otorrhoea and episodes of distress/crying) were rated 'no' or 'very slight' problem (without need for analgesia).
Methods:
Participants were recruited from routine primary care appointments. The planned sample size was 399 children. Follow-up used parent-completed validated symptom diaries.
Results:
Delays in software deployment and configuration led to small recruitment numbers and trial closure at the end of the internal pilot. Twenty-two children (median age 5 years; 62% boys) were randomised: five, seven and 10 to immediate oral, delayed oral and immediate topical antibiotics, respectively. All children received prescriptions as randomised. Seven (32%) children fully adhered to the treatment as allocated. Symptom duration data were available for 17 (77%) children. The median (interquartile range) number of days until symptom resolution in the immediate oral, delayed oral and immediate topical antibiotic arms was 6 (4-9), 4 (3-7) and 4 (3-6), respectively. Comparative analyses were not conducted because of small numbers. There were no serious adverse events and six reports of new or worsening symptoms. Qualitative clinician interviews showed that the trial question was important. When the platform functioned as intended, it was liked. However, staff reported malfunctioning software for long periods, resulting in missed recruitment opportunities. Troubleshooting the software placed significant burdens on staff.
Limitations:
The over-riding weakness was the failure to recruit enough children.
Conclusions:
We were unable to answer the main research question because of a failure to reach the required sample size. Our experience of running an electronic platform-supported trial in primary care has highlighted challenges from which we have drawn recommendations for the National Institute for Health Research (NIHR) and the research community. These should be considered before such a platform is used again.
Trial Registration:
Current Controlled Trials ISRCTN12873692 and EudraCT 2017-003635-10.
Funding:
This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 67. See the NIHR Journals Library website for further project information.
More Related Videos
07:11Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
03:47A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Related Concept Videos
Tonsillitis II: Management
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Antimicrobial Effectiveness
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption